Immune-checkpoint inhibitors (ICIs) are being tested as neoadjuvant therapies in various
solid tumours, including in patients with head and neck squamous cell carcinoma (HNSCC) …

Metastatic cervical lymph nodes are a frequent finding in head and neck squamous cell
carcinoma (HNSCC). If a non-surgical approach is primarily chosen, a therapy response …

Oral Squamous Cell Carcinoma (OSCC) is the most common malignant tumor of the oral
cavity. Despite recent advances in the field of oral cancer therapy, including the introduction …

Oral cancer, representing 2–4% of all cancer cases, predominantly consists of Oral
Squamous Cell Carcinoma (OSCC), which makes up 90% of oral malignancies. Early …

Purpose To evaluate the efficacy and laryngeal function preservation of neoadjuvant
treatment with chemotherapy and immune checkpoint inhibitor for locally advanced …

The neck control strategies of early-stage oral squamous cell carcinoma (OSCC) patients
with clinical node-negative neck remain uncertain. These patients could be benefit from …

Head and neck cancers, representing the seventh most common malignancy globally, have
seen a shift in causative factors from traditional smoking and alcohol use to human …

Oral squamous cell carcinoma (OSCC), representing more than 90% of oral cavity cancer, is
characterized by a high risk of neck regional lymph node (LN) metastasis, especially the …

Head and neck cancers are being diagnosed more frequently in elderly patients and at
advanced stages. In these cases, standard treatment methods are often not feasible due to …

Zusammenfassung Hintergrund Tumoren des Nasopharynx (NPC), der Nasenhaupt-und
nebenhöhlen, der Speicheldrüsen und der Schilddrüse (SD-CA) sind gegenüber Kopf-Hals …